JOHANNESBURG, 1ST SEPTEMBER 2016: From today all people living with HIV in South Africa are eligible to receive antiretroviral therapy (ART) in the public healthcare system. Previously only people with CD4 counts of 500 cells/mm3 or less were eligible for ART.
The Treatment Action Campaign (TAC) welcomes this development. Last year the landmark START trial showed that starting ART earlier is better for your health than waiting for your immune system to weaken. Based on the findings from the START trial we updated our position on ART in July 2015 and called for all people...Read more